Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application

• Published in: Advanced drug delivery reviews 2021-11, Vol.178, p.113990-113990, Article 113990
• Main Authors: Ragelle, Héloïse, Rahimian, Sima, Guzzi, Elia A., Westenskow, Peter D., Tibbitt, Mark W., Schwach, Grégoire, Langer, Robert
• Format: Article
• Language: English
• Subjects: 3D printing; Additive manufacturing; Drug delivery systems; Drug Design; Drug Industry; Humans; Pharmaceutical Preparations - chemical synthesis; Pharmaceutical Preparations - chemistry
• ISSN: 0169-409X; 1872-8294
• DOI: 10.1016/j.addr.2021.113990

[Display omitted] Additive manufacturing (AM) or 3D printing is enabling new directions in product design. The adoption of AM in various industrial sectors has led to major transformations. Similarly, AM presents new opportunities in the field of drug delivery, opening new avenues for improved patient care. In this review, we discuss AM as an innovative tool for drug product design. We provide a brief overview of the different AM processes and their respective impact on the design of drug delivery systems. We highlight several enabling features of AM, including unconventional release, customization, and miniaturization, and discuss several applications of AM for the fabrication of drug products. This includes products that have been approved or are in development. As the field matures, there are also several new challenges to broad implementation in the pharmaceutical landscape. We discuss several of these from the regulatory and industrial perspectives and provide an outlook for how these issues may be addressed. The introduction of AM into the field of drug delivery is an enabling technology and many new drug products can be created through productive collaboration of engineers, materials scientists, pharmaceutical scientists, and industrial partners.